|
1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136(5):E359-E86 doi: 10.1002/ijc.29210[published Online First: Epub Date]|. 2. United States Department of Labor. Workers on flexible and shift schedules in May 2004. 2005. http://www.bls.gov/news.release/pdf/flex.pdf (accessed 23 Jun 2016) 3. Eurofond. Sixth European Working Conditions Survey. 2015. Secondary Sixth European Working Conditions Survey. http://www.eurofound.europa.eu/sites/default/files/ef_publication/field_ef_document/ef1568en.pdf (accessed 23 Jun 2016) 4. Straif K, Baan R, Grosse Y, et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 2007;8(12):1065-66 doi: 10.1016/s1470-2045(07)70373-x[published Online First: Epub Date]|. 5. Megdal SP, Kroenke CH, Laden F, et al. Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer 2005;41(13):2023-32 doi: 10.1016/j.ejca.2005.05.010[published Online First: Epub Date]|. 6. Schernhammer ES, Laden F, Speizer FE, et al. Rotating night shifts and risk of breast cancer in women participating in the nurses'' health study. J Natl Cancer Inst 2001;93(20):1563-68 7. Costa G, Haus E, Stevens R. Shift work and cancer - considerations on rationale, mechanisms, and epidemiology. Scand J Work Environ Health 2010;36(2):163-79 8. Davis S, Mirick DK. Circadian disruption, shift work and the risk of cancer: A summary of the evidence and studies in Seattle. Cancer Causes Control 2006;17(4):539-45 doi: 10.1007/s10552-005-9010-9[published Online First: Epub Date]|. 9. Sigurdardottir LG, Valdimarsdottir UA, Fall K, et al. Circadian disruption, sleep Loss, and prostate cancer risk: a systematic review of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2012;21(7):1002-11 doi: 10.1158/1055-9965.epi-12-0116[published Online First: Epub Date]|. 10. Band PR, Le ND, Fang R, et al. Cohort study of air Canada pilots: mortality, cancer incidence, and leukemia risk. Am J Epidemiol 1996;143(2):137-43 11. Demers PA, Checkoway H, Vaughan TL, et al. Cancer incidence among firefighters in Seattle and Tacoma, Washington (United States). Cancer Causes Control 1994;5(2):129-35 doi: 10.1007/bf01830258[published Online First: Epub Date]|. 12. Lin S-Y, Lin C-L, Hsu W-H, et al. A comparison of cancer incidence among physician specialists and the general population: a Taiwanese cohort study. J Occup Health 2013;55(3):158-66 13. Rao D, Yu H, Bai Y, et al. Does night-shift work increase the risk of prostate cancer? a systematic review and meta-analysis. Onco Targets Ther 2015;8:2817-26 doi: 10.2147/ott.s89769[published Online First: Epub Date]|. 14. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009;6(7) doi: 10.1371/journal.pmed.1000100[published Online First: Epub Date]|. 15. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology - a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283(15):2008-12 doi: 10.1001/jama.283.15.2008[published Online First: Epub Date]|. 16. Wells G, Shea B, O''Connell D. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Health Research Institute, 2009. 17. Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. Cochrane Collabroration, 2011. 18. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992;135(11):1301-09 19. Orsini N, Li R, Wolk A, et al. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 2012;175(1):66-73 doi: 10.1093/aje/kwr265[published Online First: Epub Date]|. 20. Spiegelman D, Hertzmark E, Wand HC. Point and interval estimates of partial population attributable risks in cohort studies: examples and software. Cancer Causes Control 2007;18(5):571-79 doi: 10.1007/s10552-006-0090-y[published Online First: Epub Date]|. 21. Begg CB, Mazumdar M. Operating characteristics of a bank correlation test for publication bias. Biometrics 1994;50(4):1088-101 doi: 10.2307/2533446[published Online First: Epub Date]|. 22. Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34 23. Conlon M, Lightfoot N, Kreiger N. Rotating shift work and risk of prostate cancer. Epidemiol 2007;18(1):182-83 doi: 10.1097/01.ede.0000249519.33978.31[published Online First: Epub Date]|. 24. Gapstur SM, Diver WR, Stevens VL, et al. Work schedule, sleep duration, insomnia, and risk of fatal prostate cancer. Am J Prev Med 2014;46(3 Suppl 1):S26-33 doi: 10.1016/j.amepre.2013.10.033[published Online First: Epub Date]|. 25. Hammer GP, Emrich K, Nasterlack M, et al. Shift work and prostate cancer incidence in industrial workers a historical cohort study in a German chemical company. Dtsch Arztebl Int 2015;112(27-28):463-70 doi: 10.3238/arztebl.2015.0463[published Online First: Epub Date]|. 26. Kubo T, Oyama I, Nakamura T, et al. Industry-based retrospective cohort study of the risk of prostate cancer among rotating-shift workers. Int J Urol 2011;18(3):206-11 doi: 10.1111/j.1442-2042.2010.02714.x[published Online First: Epub Date]|. 27. Kubo T, Ozasa K, Mikami K, et al. Prospective cohort study of the risk of prostate cancer among rotating-shift workers: findings from the Japan collaborative cohort study. Am J Epidemiol 2006;164(6):549-55 doi: 10.1093/aje/kwj232[published Online First: Epub Date]|. 28. Papantoniou K, Castano-Vinyals G, Espinosa A, et al. Night shift work, chronotype and prostate cancer risk in the MCC-Spain case-control study. Int J Cancer 2014 doi: 10.1002/ijc.29400[published Online First: Epub Date]|. 29. Parent ME, El-Zein M, Rousseau MC, et al. Night work and the risk of cancer among men. Am J Epidemiol 2012;176(9):751-9 doi: 10.1093/aje/kws318[published Online First: Epub Date]|. 30. Schwartzbaum J, Ahlbom A, Feychting M. Cohort study of cancer risk among male and female shift workers. Scand J Work Environ Health 2007;33(5):336-43 doi: 10.5271/sjweh.1150[published Online First: Epub Date]|. 31. Ahn Y-S, Jeong K-S, Kim K-S. Cancer morbidity of professional emergency responders in Korea. Am J Ind Med 2012;55(9):768-78 doi: 10.1002/ajim.22068[published Online First: Epub Date]|. 32. Bates MN. Registry-based case-control study of cancer in California firefighters. Am J Ind Med 2007;50(5):339-44 doi: 10.1002/ajim.20446[published Online First: Epub Date]|. 33. Bates MN, Fawcett J, Garrett N, et al. Is testicular cancer an occupational disease of fire fighters? Am J Ind Med 2001;40(3):263-70 doi: 10.1002/ajim.1097[published Online First: Epub Date]|. 34. Daniels RD, Kubale TL, Yiin JH, et al. Mortality and cancer incidence in a pooled cohort of US firefighters from San Francisco, Chicago and Philadelphia (1950-2009). Occup Environ Med 2014;71(6):388-97 doi: 10.1136/oemed-2013-101662[published Online First: Epub Date]|. 35. Eriksson M, Hardell L, Malker H, et al. Increased cancer incidence in physicians, dentists, and health care workers. Oncol Rep 1998;5(6):1413-18 36. Firth HM, Cooke KR, Herbison GP. Male cancer incidence by occupation: New Zealand, 1972-1984. Int J Epidemiol 1996;25(1):14-21 doi: 10.1093/ije/25.1.14[published Online First: Epub Date]|. 37. Gu JK CL, Burchfiel CM, Andrew ME, Violanti JM. Cancer incidence among police officers in a U.S. northeast region: 1976-2006. Int J Emerg Ment Health 2011;13(4):279-89 38. Haldorsen T, Reitan JB, Tveten U. Cancer incidence among Norwegian airline cabin attendants. Int J Epidemiol 2001;30(4):825-30 doi: 10.1093/ije/30.4.825[published Online First: Epub Date]|. 39. Hammer GP, Auvinen A, De Stavola BL, et al. Mortality from cancer and other causes in commercial airline crews: a joint analysis of cohorts from 10 countries. Occup Environ Med 2014;71(5):313-22 doi: 10.1136/oemed-2013-101395[published Online First: Epub Date]|. 40. Innos K, Rahu K, Baburin A, et al. Cancer incidence and cause-specific mortality in male and female physicians: a cohort study in Estonia. Scand J Public Health 2002;30(2):133-40 doi: 10.1080/14034940210133735[published Online First: Epub Date]|. 41. Kang D, Davis LK, Hunt P, et al. Cancer incidence among male Massachusetts firefighters, 1987-2003. Am J Ind Med 2008;51(5):329-35 doi: 10.1002/ajim.20549[published Online First: Epub Date]|. 42. Klein-Kremer A, Liphshitz I, Haklai Z, et al. Cancer incidence among physicians in Israel. Isr Med Assoc J 2014;16(7):412-17 43. Ma F, Fleming LE, Lee DJ, et al. Cancer incidence in Florida professional firefighters, 1981 to 1999. J Occup Environ Med 2006;48(9):883-88 doi: 10.1097/01.jom.000235862.12518.04[published Online First: Epub Date]|. 44. Pukkala E, Martinsen JI, Lynge E, et al. Occupation and cancer - follow-up of 15 million people in five Nordic countries. Acta Oncol 2009;48(5):646-790 doi: 10.1080/02841860902913546[published Online First: Epub Date]|. 45. Pukkala E, Martinsen JI, Weiderpass E, et al. Cancer incidence among firefighters: 45 years of follow-up in five Nordic countries. Occup Environ Med 2014;71(6):398-404 doi: 10.1136/oemed-2013-101803[published Online First: Epub Date]|. 46. Lee Y-S, Hsu C-C, Weng S-F, et al. Cancer Incidence in Physicians A Taiwan National Population-based Cohort Study. Med 2015;94(47) doi: 10.1097/md.0000000000002079[published Online First: Epub Date]|. 47. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2015. CA Cancer J Clin 2015;65(1):5-29 doi: 10.3322/caac.21254[published Online First: Epub Date]|. 48. Center MM, Jemal A, Lortet-Tieulent J, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol 2012;61(6):1079-92 doi: 10.1016/j.eururo.2012.02.054[published Online First: Epub Date]|. 49. Wang F, Yeung KL, Chan WC, et al. A meta-analysis on dose-response relationship between night shift work and the risk of breast cancer. Ann Oncol 2013;24(11):2724-32 doi: 10.1093/annonc/mdt283[published Online First: Epub Date]|. 50. Moretti RM, Marelli MM, Maggi R, et al. Antiproliferative action of melatonin on human prostate cancer LNCaP cells. Oncol Rep 2000;7(2):347-51 51. Siu SWF, Lau KW, Tam PC, et al. Melatonin and prostate cancer cell proliferation: Interplay with castration, epidermal growth factor, and androgen sensitivity. Prostate 2002;52(2):106-22 doi: 10.1002/pros.10098[published Online First: Epub Date]|. 52. Martinez-Campa C, Alonso-Gonzalez C, Mediavilla MD, et al. Melatonin inhibits both ER alpha activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium. J Pineal Res 2006;40(4):291-96 doi: 10.1111/j.1600-079X.2006.00315.x[published Online First: Epub Date]|. 53. Tam CW, Shiu SYW. Functional interplay between melatonin receptor-mediated antiproliferative signaling and androgen receptor signaling in human prostate epithelial cells: potential implications for therapeutic strategies against prostate cancer. J Pineal Res 2011;51(3):297-312 doi: 10.1111/j.1600-079X.2011.00890.x[published Online First: Epub Date]|. 54. Hill SM, Frasch T, Xiang S, et al. Molecular Mechanisms of melatonin anticancer effects. Integr Cancer Ther 2009;8(4):337-46 doi: 10.1177/1534735409353332[published Online First: Epub Date]|. 55. Jung-Hynes B, Huang W, Reiter RJ, et al. Melatonin resynchronizes dysregulated circadian rhythm circuitry in human prostate cancer cells. J Pineal Res 2010;49(1):60-68 doi: 10.1111/j.1600-079X.2010.00767.x[published Online First: Epub Date]|. 56. Carrillo-Vico A, Guerrero JM, Lardone PJ, et al. A review of the multiple actions of melatonin on the immune system. Endocr 2005;27(2):189-200 doi: 10.1385/endo:27:2:189[published Online First: Epub Date]|. 57. Zhu Y, Stevens RG, Hoffman AE, et al. Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study. Cancer Res 2009;69(24):9315-22 doi: 10.1158/0008-5472.can-09-0648[published Online First: Epub Date]|. 58. Erren TC, Morfeld P. Computing chronodisruption: How to avoid potential chronobiological errors in epidemiological studies of shift work and cancer. Chronobiol Int 2014;31(4):589-99 doi: 10.3109/07420528.2013.877921[published Online First: Epub Date]|. 59. Stevens RG, Hansen J, Costa G, et al. Considerations of circadian impact for defining ''shift work'' in cancer studies: IARC Working Group Report. Occup Environ Med 2011;68(2):154-62 doi: 10.1136/oem.2009.053512[published Online First: Epub Date]|.
|